Many Drug Products
Total Trials
9
As Lead Sponsor
8
As Collaborator
1
Total Enrollment
1,494
NCT02890511
A Study DHP107, a Novel Oral Paclitaxel Formulation, in Patients With Advanced Solid Tumours or Gastric Cancer
Phase: Phase 1/2
Role: Lead Sponsor
Start: Aug 31, 2010
Completion: Oct 31, 2012
NCT01839773
Phase 3 Study to Compare Efficacy and Safety of DHP107 vs. Taxol® in Patients With Metastatic or Recurrent Gastric Cancer
Phase: Phase 3
Start: Mar 31, 2013
Completion: Aug 31, 2015
NCT03055741
Study of DHP1401 in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil(DRAMA)
Phase: Phase 2
Start: Dec 28, 2016
Completion: Aug 31, 2019
NCT03315364
Oral Paclitaxel Trial In Recurrent and Metastatic Breast Cancer As 1st Line Therapy
Phase: Phase 2/3
Start: Dec 18, 2017
Completion: Dec 31, 2025
NCT03326102
Oral Paclitaxel Efficacy Safety and PK in Recurrent and Metastatic Breast Cancer
Start: Jul 6, 2018
Completion: Dec 13, 2022
NCT04675528
Food Effect on Pharmacokinetics and Safety of DHP107 (Liporaxel®) FEEL Study
Phase: Phase 1
Start: May 4, 2021
Completion: Dec 12, 2022
NCT05503953
Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential Hypertension Inadequately Controlled With AGLS
Role: Collaborator
Start: Sep 5, 2022
Completion: Jul 31, 2024
NCT06395155
A Phase 1 Clinical Trial DHP2306R1 and DHP2306R2 in Healthy Adult Volunteers
Start: Oct 26, 2023
Completion: Dec 7, 2023
NCT06318845
Phase 1 Study of DHP2302R1 and DHP2302R2 in Healthy Adult Volunteers
Start: Mar 4, 2024
Completion: May 7, 2024
Loading map...